Evidence map›Paper›PMID 41818613›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

From Cell-Free Transcriptomes to Single-Cell Landscapes: Biomarker Discovery and Originating Cell Alteration Analysis via Graph Matrix Factorization.

Wenxiang Zhang, Wenjing Zhang, Hang Wei, Shiyan Liu, Junliang Shang, Weijie Gong, Hanwen Cheng, Xiujuan Lei, Yuhui Kou, Baoguo Jiang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wenxiang ZhangShenzhen Clinical Research Center for Trauma treatment, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.ORCID https://orcid.org/0000-0002-8926-1615
Wenjing ZhangShenzhen Clinical Research Center for Trauma treatment, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.
Hang WeiSchool of Computer Science and Technology, Xidian University, Xi'an, Shaanxi, China.
Shiyan LiuShenzhen Clinical Research Center for Trauma treatment, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.
Junliang ShangSchool of Computer Science, Qufu Normal University, Rizhao, China.ORCID https://orcid.org/0000-0002-8488-2228
Weijie GongDepartment of Family Medicine, Shenzhen University Medical School, Shenzhen, Guangdong, China.
Hanwen ChengNational Center for Trauma Medicine, Beijing, China.
Xiujuan LeiSchool of Artificial Intelligence and Computer Science, Shaanxi Normal University, Xi'an, China.ORCID https://orcid.org/0000-0002-9901-1732
Yuhui KouNational Center for Trauma Medicine, Beijing, China.
Baoguo JiangShenzhen Clinical Research Center for Trauma treatment, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.

Funding

Basic Science Center Program of National Natural Science Foundation of China T2288102Beijing Municipal Natural Science Foundation - Fengtai Joint Fund 2024FTQY037Guangdong Medical Research Fund B2025088National Key R&D Program Priority Special Projects of China 2024YFC3016605National Natural Science Foundation of China 32371048Shenzhen Clinical Research Center for Trauma Treatment 20230731111952004Shenzhen Medical Research Fund D2401015The National Key R&D Program of China, MOST 2023YFC2509900
6 · The paper itself

Abstract

Characterizing the cellular origin and disease-driven dynamics of cfRNA is essential for integrating cfRNA profiling into clinical workflows and precision-medicine strategies. Most cfRNA studies are restricted to bulk-level analyses, which preclude detailed analysis of alterations in the cellular origins of cfRNA. Single-cell RNA sequencing reveals cellular heterogeneity and communication, but its application to cfRNA is limited by diverse cellular origins, leaving a critical gap in understanding functional alterations in cfRNA biomarker-originating cells. In this work, we propose CellFreeGMF, a tool designed to enable diagnosis classification of clinical samples, identify cfRNA biomarkers, and analyze the alterations in their originating cells based on graph matrix factorization. Furthermore, by utilizing cell-cell communication analysis, CellFreeGMF investigates the functional alterations occurring in the cfRNA originating cells under disease conditions. We validate CellFreeGMF on diverse cell-free RNA transcriptome clinical datasets. In the case of pancreatic ductal adenocarcinoma (PDAC), CellFreeGMF not only identified cfRNA biomarkers but also traced their cellular origins to myeloid and T-cell populations. Further analysis revealed significant transcriptomic differences in these cell populations between disease and normal groups. Our user-friendly CellFreeGMF toolkit (https://cellfreegmf.readthedocs.io/) enables identifying cfRNA biomarkers and elucidating pathophysiological changes in their originating cells.

Indexed as

Biomarkers, TumorCarcinoma, Pancreatic DuctalCell-Free Nucleic AcidsPancreatic NeoplasmsSingle-Cell AnalysisTranscriptomeBiomarkersGene Expression ProfilingHumansSingle-Cell Gene Expression AnalysisBiomarkersBiomarkers, TumorCell-Free Nucleic AcidscfRNA biomarker identificationcfRNA originating cellsclinical sample diagnostic classificationgraph matrix factorization

Identifiers

PMID41818613
PMCPMC13205738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.